Fever management in critically ill COVID-19 patients: a retrospective analysis.


Journal

Minerva anestesiologica
ISSN: 1827-1596
Titre abrégé: Minerva Anestesiol
Pays: Italy
ID NLM: 0375272

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 3 8 2021
medline: 20 11 2021
entrez: 2 8 2021
Statut: ppublish

Résumé

Fever has been reported as a common symptom in COVID-19 patients. The aim of the study was to describe the characteristics of COVID-19 critically ill patients with fever and to assess if fever management had an impact on some physiologic variables. This is a retrospective monocentric cohort analysis of critically ill COVID-19 patients admitted to the Department of Intensive Care Unit (ICU) of Erasme Hospital, Brussels, Belgium, between March 2020 and May 2020. Fever was defined as body temperature ≥38 °C during the ICU stay. We assessed the independent predictors of fever during ICU stay. We reported the clinical and physiological variables before and after the first treated episode of fever during the ICU stay. A total of 72 critically ill COVID-19 patients were admitted to the ICU over the study period and were all eligible for the final analysis; 53 (74%) of them developed fever, after a median of 4 [0-13] hours since ICU admission. In the multivariable analysis, male gender (OR 5.41 [C.I. 95% 1.34-21.92]; P=0.02) and low PaO<inf>2</inf>/FiO<inf>2</inf> ratio (OR 0.99 [C.I. 95% 0.99-1.00]; P=0.04) were independently associated with fever. After the treatment of the first febrile episode, heart rate and respiratory rate significantly decreased together with an increase in PaO<inf>2</inf> and SaO<inf>2</inf>. In our study, male gender and severe impairment of oxygenation were independently associated with fever in critically ill COVID-19 patients. Fever treatment reduced heart rate and respiratory rate and improved systemic oxygenation.

Sections du résumé

BACKGROUND
Fever has been reported as a common symptom in COVID-19 patients. The aim of the study was to describe the characteristics of COVID-19 critically ill patients with fever and to assess if fever management had an impact on some physiologic variables.
METHODS
This is a retrospective monocentric cohort analysis of critically ill COVID-19 patients admitted to the Department of Intensive Care Unit (ICU) of Erasme Hospital, Brussels, Belgium, between March 2020 and May 2020. Fever was defined as body temperature ≥38 °C during the ICU stay. We assessed the independent predictors of fever during ICU stay. We reported the clinical and physiological variables before and after the first treated episode of fever during the ICU stay.
RESULTS
A total of 72 critically ill COVID-19 patients were admitted to the ICU over the study period and were all eligible for the final analysis; 53 (74%) of them developed fever, after a median of 4 [0-13] hours since ICU admission. In the multivariable analysis, male gender (OR 5.41 [C.I. 95% 1.34-21.92]; P=0.02) and low PaO<inf>2</inf>/FiO<inf>2</inf> ratio (OR 0.99 [C.I. 95% 0.99-1.00]; P=0.04) were independently associated with fever. After the treatment of the first febrile episode, heart rate and respiratory rate significantly decreased together with an increase in PaO<inf>2</inf> and SaO<inf>2</inf>.
CONCLUSIONS
In our study, male gender and severe impairment of oxygenation were independently associated with fever in critically ill COVID-19 patients. Fever treatment reduced heart rate and respiratory rate and improved systemic oxygenation.

Identifiants

pubmed: 34337916
pii: S0375-9393.21.15711-6
doi: 10.23736/S0375-9393.21.15711-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1217-1225

Commentaires et corrections

Type : CommentIn

Auteurs

Lorenzo Peluso (L)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium - lorenzopeluso80@gmail.com.

Federica Montanaro (F)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.
Intensive Care Unit, Department of Morphology, Surgery and Experimental Medicine, Sant'Anna University Hospital, Ferrara, Italy.

Antonio Izzi (A)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Alessandra Garufi (A)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Narcisse Ndieugnou Djangang (N)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Amandine Polain (A)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Andrea Minini (A)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Elisa Gouvea Bogossian (E)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Filippo Annoni (F)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Savino Spadaro (S)

Intensive Care Unit, Department of Morphology, Surgery and Experimental Medicine, Sant'Anna University Hospital, Ferrara, Italy.

Jacques Creteur (J)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Fabio S Taccone (FS)

Department of Intensive Care Medicine, Erasme University Hospital, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH